RiteeshGrandhi/sciclaimeval-shared-task huggingface dataset:
Conclusions
Our study indicates a high IBV with the booster dose (88.1%), and there are factors associated with a higher IBV, including male gender, people related to health sciences, adults with a good perception of the effectiveness and protective effect of the booster dose, with the latter emerging as the most influential determinant. Likewise, our findings indicate that individuals aged 45 and older exhibit a lower IBV. Among all the agents studied, the recommendation of doctors emerged as the most influential on IBV while the recommendation of politicians exerted the least influence.

We recommend an increased dissemination of the safety and effectiveness of the vaccine on social networks, television and radio. Additionally, we suggest greater communication by doctors and health personnel towards patients who have doubts or fears about the booster vaccination. We recommend campaigns against fake news since these are usually shared among friends and family, influencing the IBV. Finally, efforts should be directed towards reaching at-risk populations, particularly older adults and people in remote areas without internet access.
(A) Sociodemographic characteristics of the booster dose COVID-19 in Peru, July 2022 (n= 924).
Bivariate analysis of study characteristics according to intention to be vaccinated with the booster dose COVID-19 in Peru, July 2022 (n= 924).
Factors associated with the intention to be vaccinated with the COVID-19 booster dose in Peru, July 2022.